Phio Pharmaceuticals (PHIO) Operating Leases (2019 - 2021)
Historic Operating Leases for Phio Pharmaceuticals (PHIO) over the last 3 years, with Q3 2021 value amounting to $314000.0.
- Phio Pharmaceuticals' Operating Leases fell 2831.05% to $314000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $314000.0, marking a year-over-year decrease of 2831.05%. This contributed to the annual value of $411000.0 for FY2020, which is 2065.64% down from last year.
- As of Q3 2021, Phio Pharmaceuticals' Operating Leases stood at $314000.0, which was down 2831.05% from $354000.0 recorded in Q2 2021.
- Phio Pharmaceuticals' Operating Leases' 5-year high stood at $542000.0 during Q3 2019, with a 5-year trough of $314000.0 in Q3 2021.
- Its 3-year average for Operating Leases is $443818.2, with a median of $465000.0 in 2019.
- In the last 5 years, Phio Pharmaceuticals' Operating Leases changed by 0.0% in 2020 and then plummeted by 2831.05% in 2021.
- Quarter analysis of 3 years shows Phio Pharmaceuticals' Operating Leases stood at $518000.0 in 2019, then decreased by 20.66% to $411000.0 in 2020, then dropped by 23.6% to $314000.0 in 2021.
- Its Operating Leases was $314000.0 in Q3 2021, compared to $354000.0 in Q2 2021 and $383000.0 in Q1 2021.